Added to YB: 2025-09-09
Pitch date: 2025-09-06
AQST [bullish]
Aquestive Therapeutics, Inc.
+12.91%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Aquestive Therapeutics, Inc. operates as a pharmaceutical company in the United States and internationally.
Market Cap
$657.6M
Pitch Price
$5.50
Price Target
N/A
Dividend
N/A
EV/EBITDA
-10.67
P/E
-7.75
EV/Sales
13.13
Sector
Pharmaceuticals
Category
growth
Show full summary:
Aquestive Therapeutics: Disrupting the $2.9B Epinephrine Market with Needle-Free Anaphylm
AQST: Anaphylm sublingual film targets $2.87B epinephrine market as needle-free EpiPen alternative. Portable, weather-resistant, cheaper than $600-750 EpiPen 2-pack. 40% of high-risk patients don't carry auto-injectors due to inconvenience/fear. FDA skipped AdCom, approval likely early 2026. Est $300-400M peak US sales.
Read full article (2 min)